Medigate announced it was named to the Constellation ShortList for Medical Device Security in Q3 2019. Medigate’s unique medical device security and asset management platform addresses both clinical Internet of Medical Things (IoMT) and general IoT devices, enabling accurate and comprehensive device discovery, contextual and behavioral anomaly detection, and clinical policy enforcement for health care organizations’ entire clinical networks.
Medigate provides three capabilities for effective IT security: visibility into all network connected devices, detection of potential threats and automated prevention of attacks. These capabilities are specifically designed for the health care industry, differentiating Medigate from other solutions.
“In recent years, we’ve seen an increase of cyberattacks in the health care sector due to vulnerabilities within medical device networks, creating exposure and even affecting the quality of patient care,” said Jonathan Langer, co-founder and CEO of Medigate. “Being named to the Constellation ShortList validates our efforts in helping health care organizations protect everything on their networks and overcome the security threats that the industry is facing today.”
Constellation Research advises leaders on leveraging disruptive technologies to achieve business model transformation. Products and services named to the Constellation ShortList meet the threshold criteria for this category as determined through client inquiries, partner conversations, customer references, vendor selection projects, market share and internal research. The portfolio is frequently updated every six months with the rapidly changing market conditions.
For more information, visit medigate.io.
Disclaimer: Constellation Research does not endorse any solution or service named in its research.
